
Sign up to save your podcasts
Or
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.
291 Listeners
314 Listeners
48 Listeners
861 Listeners
492 Listeners
14 Listeners
90 Listeners
25 Listeners
513 Listeners
132 Listeners
349 Listeners
183 Listeners
365 Listeners
5 Listeners
79 Listeners